Tuesday, November 18, 2025
CSL to Invest Approximately 1.5 Billion in U.S. to Manufacture Plasma-Derived Therapies
CSL to Invest Approximately 1.5 Billion in U.S. to Manufacture Plasma-Derived Therapies
The Economic Alliance works diligently to report in a timely manner on things like local business expansion, new business development, new and enhanced development incentives, economic news and other items of interest to our community investors and investor prospects.
Sign up for our e-newsletter today to receive the Economic Alliance’s quarterly reports. For more regular updates, connect with us on Facebook, Twitter and LinkedIn and follow our news feed.
News Feed
Tuesday, December 5, 2023
CSL Named 2023 IL Manufacturer of the Year by IMA
The Illinois Manufacturers’ Association is proud to announce CSL Behring’s selection as the recipient of the 2023 Barry L. MacLean Manufacturer of the Year that will be awarded at the IMA’s 130th Annual Luncheon on December 8, 2023, at the Sheraton Grand Chicago.
Monday, April 20, 2020
CSL Behring Fights Covid-19 with CoVIg-19 Plasma Alliance
Experts from the world’s leading plasma companies have come together to create a new alliance aimed at treating the new coronavirus. Partners include CSL Behring, the third largest biotech company globally, currently underway with a 1.8 million SF expansion of its Kankakee, Illinois, production site.
Thursday, April 2, 2020
Rest on Your Laurels, Kankakee County.
Change is the universe’s default. Progress, at its best, is positive change. As we together weather the unprecedented global reverberations presented by the novel coronavirus (COVID-19) pandemic, subsequent shelter-in-place precautions, and tremendous personal and business losses, it is tempting to abandon the notion of progress. But that would be a tragic mistake.